DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Reset all filters
01 1BUPRENORPHINE HYDROCHLORIDE
02 1BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
03 1INTERMEZZO
04 1ISOSORBIDE DINITRATE
05 1NITROGLYCERIN
06 1NITROSTAT
07 1ZOLPIDEM TARTRATE
Reset all filters
01 121134
02 122328
03 186055
04 1201066
05 1204299
06 1205022
07 1208191
Reset all filters
01 6No
02 1Yes


Drug : NITROGLYCERIN
Dosage Form : TABLET; SUBLINGUAL
Application Number : 208191
Country : US
Patented : No
Drug : ISOSORBIDE DINITRATE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 86055
Country : US
Patented : No

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 205022
Country : US
Patented : No

Drug : ZOLPIDEM TARTRATE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 204299
Country : US
Patented : No

Drug : INTERMEZZO
Dosage Form : TABLET; SUBLINGUAL
Application Number : 22328
Country : US
Patented : Yes

Drug : NITROSTAT
Dosage Form : TABLET; SUBLINGUAL
Application Number : 21134
Country : US
Patented : No

Drug : BUPRENORPHINE HYDROCHLORIDE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 201066
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF


